Roundup: Diabetes coaching app Breathe Wellbeing bags $6M and more briefs

Breathe Wellbeing Scores $6M in Pre-Series B Funding

India-based diabetes care startup Breathe Wellbeing has raised $6 million (Rs 500 million) in a pre-series B round led by 3One4 Capital, Accel and General Catalyst.

Launched in 2020, the company focuses on behavioral and lifestyle changes to reduce and reverse the risk of type 2 diabetes. It offers clinically proven digital programs that are personalized for each user and also comes with coaching support and gamified content. It is said to clinically help lower HbA1c, reduce weight and reduce patients’ dependence on medication.

According to the company, it will use its fresh funds to expand its core team, strengthen its health coaching academy, scale its platform and enhance user experience.


New health supplement app Pillwork goes live.

A new mobile app in South Korea helps consumers buy health supplements.

Now available on both iOS and Android devices, the Pillwork app provides trusted information on nearly 20,000 health supplements on its platform. It includes blogs, articles and encyclopedias and allows users to share their opinions about a product, which others can check and review.

The app categorizes products for easy searching, as well as identifies the risk of taking a particular product for a specific disease.

Pillwork also has experts on board who can advise users, as well as provide AI-generated curated information that users may need. Moreover, it can also scan off-the-shelf pill bottles and provide instant information on them.


In South Korea, Alzheimer’s can be diagnosed with artificial eye lenses.

The Korea Institute of Machinery and Materials (KIMM) has developed an intraocular lens that can diagnose Alzheimer’s disease at an early stage.

Developed in partnership with Yonsei University’s Yongin Severance Hospital and Gangnam Severance Hospital, the implantable artificial lens is made with a bioresponsive hydrogel that exhibits a MoirĂ© pattern as it reacts to a target Alzheimer’s biomarker. Is.

Its pattern detection does not require the use of electrochemical or fluorescent labels commonly used in other biosensors, nor does it require external power or light sources.

gave the studysupported by the Nanomaterials Technology Development Project of the South Korean Ministry of Science and ICT, was published in Bioactive Materials, a biomaterials journal.

#Roundup #Diabetes #coaching #app #Breathe #Wellbeing #bags #briefs

Leave a Reply

Your email address will not be published. Required fields are marked *